Clinical Chemistry Link to Randox Laboratories Web Site spacer gif
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2004.047662v1, 2005; 10.1373/clinchem.2004.047662
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2004.047662v1
51/8/1397    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishii, J.
Right arrow Articles by Hishida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishii, J.
Right arrow Articles by Hishida, H.

Received on December 31, 2004
Accepted on May 3, 2005

Proteomics and Protein Markers

Prognostic Value of Serum Concentration of Heart-Type Fatty Acid-Binding Protein Relative to Cardiac Troponin T on Admission in the Early Hours of Acute Coronary Syndrome

Junnichi Ishii 1, Yukio Ozaki 2, Jingchao Lu 2, Fumihiko Kitagawa 3, Takahiro Kuno 3, Tadashi Nakano 2, Yuu Nakamura 2, Hiroyuki Naruse 2, Yoshihisa Mori 2, Shigeru Matsui 2, Hisaji Oshima 3, Masanori Nomura 2, Kouji Ezaki 2, Hitoshi Hishida 2

1 Division of Critical Care, Fujita Health University Graduate School of Health Sciences, Toyoake, Japan
2 Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan
3 Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University Hospital, Toyoake, Japan

Background: Heart-type fatty acid-binding protein (H-FABP) is proposed as an early biomarker for acute myocardial infarction (AMI), but its prognostic value is unclear in acute coronary syndrome (ACS). We evaluated the prognostic value of the H-FABP concentration relative to cardiac troponin T (cTnT) in the early hours of ACS.

Methods: Serum concentrations of H-FABP and cTnT were measured on admission in 328 consecutive patients hospitalized for ACS within 6 h after the onset of chest pain [AMI, 241 (73.5%) patients; ST-segment elevation myocardial infarction, 154 (47.0%) patients; and emergent coronary angiography within 24 h after admission, 287 (87.5%) patients]. Cardiac events, which were defined as cardiac death or subsequent nonfatal AMI, were monitored for 6 months after admission.

Results: During the 6-month follow-up period, there were 25 cardiac events, including 15 cardiac deaths and 10 subsequent nonfatal AMIs. Stepwise multivariate analyses including clinical, electrocardiographic, and biochemical variables revealed that increased H-FABP (above the median value of 9.8 µg/L), but not increased cTnT (above the median value of 0.02 µg/L), was independently associated with cardiac events in all patients [relative risk (RR) = 9.0; P = 0.0004], the subgroup of patients with ST-segment elevation myocardial infarction (RR = 11.3; P = 0.02), and the subgroup of patients with unstable angina and non-ST-segment elevation myocardial infarction (RR = 8.3; P = 0.007). The area under the ROC curve was higher for H-FABP than for cTnT (0.711 vs 0.578; P = 0.08), suggesting that H-FABP concentrations have a greater predictive capacity for cardiac events than cTnT.

Conclusion: Serum H-FABP is a potential independent predictor of cardiac events within 6 months of patient admission and may provide prognostic information superior to cTnT in the early hours of ACS.




The following articles in journals at HighWire Press have cited this article:


Home page
Eur Respir JHome page
M. Lankeit, C. Dellas, A. Panzenbock, N. Skoro-Sajer, D. Bonderman, M. Olschewski, K. Schafer, M. Puls, S. Konstantinides, and I. M. Lang
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension
Eur. Respir. J., May 1, 2008; 31(5): 1024 - 1029.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. A. de Lemos and M. O'Donoghue
The Skinny on Fatty Acid-Binding Protein
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2068 - 2070.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Kilcullen, K. Viswanathan, R. Das, C. Morrell, A. Farrin, J. H. Barth, A. S. Hall, and for the EMMACE-2 Investigators
Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values
J. Am. Coll. Cardiol., November 20, 2007; 50(21): 2061 - 2067.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Puls, C. Dellas, M. Lankeit, M. Olschewski, L. Binder, A. Geibel, C. Reiner, K. Schafer, G. Hasenfuss, and S. Konstantinides
Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism
Eur. Heart J., January 2, 2007; 28(2): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. O'Donoghue, J. A. de Lemos, D. A. Morrow, S. A. Murphy, J. L. Buros, C. P. Cannon, and M. S. Sabatine
Prognostic Utility of Heart-Type Fatty Acid Binding Protein in Patients With Acute Coronary Syndromes
Circulation, August 8, 2006; 114(6): 550 - 557.
[Abstract] [Full Text] [PDF]




spacer gif
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the American Association for Clinical Chemistry.